Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning, and genotyping.   HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR [...]

Empowering Researchers with Advanced End-to-End Analysis Tools for Single-Cell and Genetic Variation Studies. We’re thrilled to announce the much-anticipated arrival of OmicsBox 3.1, a release that brings significant improvements to single-cell data analysis with UMI-based technology support and introduces a functional enrichment tool for genetic variation analysis. It also enhances OmicsBox’s long-read transcriptome analysis options, [...]

Progress on Environment, Social and Governance (ESG) goals reflected in QIAGEN securing a „Prime“ rating and among the industry leaders with ISS-ESG rating Environment: Net-zero target validated by Science Based Targets initiative (SBTi), achieved 20% decrease in Scope 1 and 2 emissions, reduced plastic usage by 16.5% in 2022 Social: Increasing workforce diversity with 35% [...]

Cambridge, UK – Eagle Genomics (“Eagle”) is pleased to announce it has raised additional financing of £3 million (USD $4 million) with continued participation from existing investors Environmental Technologies Fund, abrdn plc, and a consortium of investors headed by Granpool Innovative Investments, to further deploy its pioneering software platform that enables corporate customers to explore and monetize on microbiome-related [...]

Gives Researchers New Project Management Capabilities, Reduces Duplication, and Improves Cross-Organization Collaboration Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced its new Dotmatics Chemicals & Materials Solution specifically designed to help R&D leaders get more insight from their data, faster. With its focus on simplifying data intelligence, the new Dotmatics Chemicals & [...]

EMERYVILLE, Calif.-- PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding diversity of antibodies customers can discover on the Beacon® optofluidic platform. The new workflow and reagents, to be commercially available by the end of the year, enable rapid, automated generation of antigen-specific, functional monoclonal [...]

Financing led by M Ventures, with participation from GreatPoint Ventures, Riverine Ventures and existing investors Cota Capital, Dynamk Capital, Elm Street Ventures, Embark Ventures, EGB Capital and Khosla Ventures Novel microfluidics-based cell engineering platform for ex-vivo cell transfection enabling efficient, flexible, and consistent payload delivery, superior cell health and streamlined workflows for seamless scalability from [...]

Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. ATLANTA--Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid’s original investor base, [...]

Novel AEX screening kit – now available for AAV6 – and an expansive suite of high-quality reagents designed to expedite plasmid production will help accelerate breakthroughs across multiple AAV constructs and workflows HOLLISTER, Calif. -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of [...]

SOUTH SAN FRANCISCO, Calif. & SAN RAFAEL, Calif. & BARCELONA---- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and IMIDomics, Inc., a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases (IMIDs), today announced a multi-program collaboration whereby Twist will utilize its [...]